Plastic surgery rollover equity is the part of a sale most surgeons understand least, and it can end up being the part that matters most. When a private equity-backed group buys your practice, it rarely pays the whole price in cash. It asks you to reinvest part of your proceeds in its company. If that company grows and sells, your stake could be worth more than you rolled. If it struggles, it could be worth very little.
This guide explains how rollover equity works, how to judge what it’s worth, how it’s taxed, and what happens at the “second bite of the apple,” when the platform itself is sold. It also covers the terms that travel with rollover: earnouts, your post-close employment agreement and your non-compete. And it’s written for two readers: surgeons weighing an offer now, and surgeons who already sold and are wondering what happens next.
Key takeaways
- Rollover equity is part of your purchase price reinvested in the buyer’s company. It’s usually tax-deferred when structured correctly (Alston & Bird).
- Its value depends on the platform’s growth, its debt, the class of equity you receive and when the sponsor sells.
- Rollover equity is a speculative investment that “may lose some or all of its value” (Roetzel & Andress).
- Your employment agreement and non-compete often matter as much as the equity. Negotiate them together.
What is plastic surgery rollover equity?
Plastic surgery rollover equity is the portion of your sale price that you reinvest in the buyer’s company, usually the management services organization or its parent, instead of taking it in cash. You become a minority owner of the larger platform, and you get paid again if and when that platform is sold.
Buyers ask for rollover for two reasons. It reduces the cash they need at closing, and it keeps you invested in the platform’s success, since your equity is worth more if the practice keeps growing. For you, it’s a chance at a second payday, with real risk attached.
How does rollover equity work in a plastic surgery deal?
At closing, you receive part of the price in cash and exchange the rest for equity in the buyer’s company. That equity is held until the private equity sponsor sells the platform or recapitalizes it. Then your stake is either paid out in cash, rolled again into the next owner, or a mix of both.
Here’s a hypothetical example, with illustrative figures only.
| Amount | |
| Agreed enterprise value of your practice | $10,000,000 |
| Cash at closing (70%) | $7,000,000 |
| Rollover equity (30%) | $3,000,000 |
Roetzel & Andress uses a similar 30% rollover in its own example, but there’s no single standard. The share varies by buyer, deal size and how much the buyer wants you invested.
Now suppose the platform is sold a few years later. What your $3 million becomes depends on how the platform performed and how much debt it carries:
| Hypothetical outcome | Change in equity value | Your stake |
| Strong growth, modest debt | 2.5x | $7,500,000 |
| Moderate growth | 1.5x | $4,500,000 |
| Flat performance, higher debt | 1.0x | $3,000,000 |
| Poor performance, heavy debt | 0.3x | $900,000 |
The point isn’t the numbers. It’s the range. Two surgeons who sold on identical headline terms can end up with very different totals depending on the platform they joined.
7 honest truths about plastic surgery rollover equity
1. It’s part of your price, not a bonus
Treat rollover as money you’ve already earned and chosen to reinvest. Compare offers on cash at closing first, then weigh the equity as upside with risk.
2. Debt sits ahead of you
Private equity platforms usually borrow to fund acquisitions. Lenders get paid before equity holders, so a highly leveraged platform needs more growth for your stake to gain value. Ask how much debt the platform carries now and how much it plans to add.
3. Not all equity is equal
Find out exactly what you receive: common or preferred units, at the holding company or an operating company, and whether the sponsor’s equity has a preference that gets paid first. Your class of equity can matter as much as its dollar amount.
4. It may depend on you staying
Roetzel & Andress notes rollover equity is often “subject to forfeiture (or a reduced purchase price) if the seller or its owners do not continue providing services.” Read the vesting, forfeiture and repurchase terms carefully.
5. You won’t control the exit
The sponsor decides when and how to sell, and drag-along rights usually require you to sell alongside it on the same terms. You may also be diluted as the platform issues new equity to other surgeons.
6. There may be no cash until the exit
Distributions before a sale aren’t guaranteed. Roetzel & Andress says plainly: “There is no guarantee that cash distributions will be made.”
7. The timeline is shorter than you think
Private equity firms hold investments for a limited period. FOCUS Investment Banking describes a five-to-seven-year hold period in physician practice deals. If you join a platform late in its hold, your second bite could come within a year or two.
Questions to ask a buyer about plastic surgery rollover equity
Before you agree to any plastic surgery rollover equity, get written answers to these:
- Which entity will I hold equity in, and what class of units?
- How much debt does the platform carry, and how much will it add?
- Does the sponsor’s equity have a preference or a higher return threshold?
- When was the fund raised, and when does the sponsor expect to sell?
- What happens to my equity if I leave, retire, become disabled or am terminated?
- Can I sell any of my equity before the exit?
- Will I receive financial statements and valuation updates each year?
A buyer that answers these clearly is usually a buyer worth trusting. Vague answers are a warning sign.
How is rollover equity taxed?
Usually, the rollover portion is tax-deferred at closing, so you pay tax on the cash you receive and defer tax on the equity until you sell it. This relies on specific tax code sections, typically Section 721 for partnership contributions or Section 351 for corporate ones. The structure has to be set up correctly before closing.
Alston & Bird explains that nearly all rollover structures rely on those two non-recognition rules, and that details like how cash and equity are allocated can trigger unexpected gain. Roetzel & Andress lists events that can cause deferred gain to be recognized later, including certain distributions and asset sales.
Taxes also interact with goodwill. If part of the value is personal goodwill sold separately, the treatment can differ again. This is one area where your tax adviser needs to be involved from the letter of intent onward, not brought in at the end. This guide isn’t tax advice.
What is the second bite of the apple in plastic surgery?
It’s the payout surgeons receive on their rollover equity when the private equity sponsor sells the platform. The first bite is the cash at your original sale. The second bite comes later, when your stake in the larger platform is sold, often at a higher value if the platform has grown.
The second bite is the main reason surgeons accept rollover equity. A platform that buys practices at add-on multiples and later sells as a much larger business at a platform multiple can produce a large return on the rolled equity. That’s the theory. In practice, the outcome depends on execution, debt and market conditions at the time of sale.
It’s also why timing matters. PitchBook reported the median US private equity hold reached 3.4 years at the end of 2024, the longest in over nine years. Several plastic surgery platforms formed in the early 2020s, so the earliest are approaching the typical exit window. Our guide to plastic surgery practice for sale explains this platform exit wave.
Already sold? What to do when your platform is sold
If you rolled equity into a platform and hear it’s being sold, you’ll face decisions quickly. You may be offered cash for your stake, the option to roll again into the new owner, or a mix. You may also be asked to sign a new employment agreement and non-compete.
A practical checklist:
- Reread your operating agreement. Know your drag-along, tag-along and information rights before talks begin.
- Ask for the waterfall. Find out how sale proceeds flow through debt, preferred equity and your class of units, and what your stake is actually worth.
- Understand the roll-again option. Rolling again defers tax and keeps upside, but resets the clock and the risk.
- Review new employment terms. A new owner may propose new compensation, a new term and a new non-compete.
- Get your own advisers. The platform’s lawyers represent the platform. Have your own attorney and tax adviser review everything.
Very little is written for surgeons at this stage, and the decisions can move a lot of money. Treat it like a second sale, because it is one.
How do earnouts work in plastic surgery deals?
An earnout is part of the price paid later, only if the practice hits agreed targets such as revenue or EBITDA over one or more years. It bridges a gap when buyer and seller disagree on value. It can add meaningful upside, but only if the targets are realistic and within your control.
Negotiate earnouts carefully. Define the metric precisely, set targets you can actually influence, protect against changes the buyer makes that affect results, and cap how long the earnout runs. TUSK Practice Sales notes that most deals combine upfront cash, rollover equity and sometimes earnouts (PR Newswire).
What should a post-close employment agreement for a surgeon include?
Your role, compensation formula, schedule, call obligations, clinical independence, term, termination rights and what happens to your equity and non-compete if you leave. TUSK reports employment agreements in plastic surgery deals typically run three to five years. Negotiate the agreement alongside price, not after.
Key points to settle:
- Compensation. How is it calculated, and how does it change if the practice grows or shrinks? Remember that lower post-sale pay raises the price, and higher pay lowers it.
- Clinical autonomy. Who decides on procedures, scheduling, staffing and marketing claims? State corporate practice of medicine rules, and laws like Vermont’s Act 133, protect physician judgment, but your contract should too.
- Termination. What happens if you’re terminated without cause, or if you leave for good reason?
- Equity links. Does leaving early trigger forfeiture or repurchase of your rollover equity?
Is a non-compete after selling a practice enforceable?
Generally, non-competes signed as part of selling a business are more likely to be enforced than those in ordinary employment contracts, as long as they’re reasonable in length and distance. But rules vary by state, and many states have limited physician non-competes. Expect both a sale non-compete and one in your employment agreement.
The federal picture changed in 2025. The FTC voted on September 5, 2025, to vacate its nationwide non-compete rule, according to the AHA, while signaling targeted enforcement. States are more active. The American Medical Association reports that Texas limited physician non-competes to one year and five miles, Pennsylvania to one year, and that Colorado carved out an exception for the purchase and sale of a business. Ask your attorney how your state treats each of your agreements.
What happens to my staff when I sell my practice?
Most buyers keep your clinical and front-desk staff, because they hold patient relationships and are costly to replace. Administrative roles may be centralized over time. Wages, benefits and titles can change as the practice joins the buyer’s systems, so ask about them directly and put important commitments in writing.
Your staff are also part of your value. A stable team makes the practice easier to integrate and more attractive to buyers. For more on preparing your team and the sale itself, see our guide on how to sell a plastic surgery practice.
How do you compare offers with different structures?
Put every offer on the same basis: cash at closing after adjustments, then the expected value and risk of rollover equity, then any earnout, then your compensation and non-compete terms. The highest headline price isn’t always the best deal. Sometimes a lower price with more cash and fairer terms leaves you better off.
A simple comparison table, built with your advisor, makes the trade-offs visible. Include the buyer’s debt level, fund timeline and track record with surgeons who’ve sold before. Our guides to plastic surgery practice valuation and who buys plastic surgery practices cover the price and buyer side.
Frequently asked questions
What is rollover equity in a plastic surgery practice sale?
It’s the part of your sale price reinvested in the buyer’s company instead of paid in cash. You become a minority owner of the larger platform and receive a second payout when that platform is sold or recapitalized. Its value depends on the platform’s growth, debt and the terms of your equity.
How much rollover equity is typical?
There’s no single standard. It varies by buyer, deal size and negotiation. Roetzel & Andress uses a 30% rollover as an example in its analysis of practice sales, but surgeons see a range. Focus on how much cash you need at closing and how much risk you’re comfortable holding.
Is rollover equity taxed at closing?
Usually not, if the deal is structured correctly. The rollover portion is typically tax-deferred under Section 721 or Section 351 of the tax code, while the cash portion is taxed at closing. Certain distributions or structuring details can trigger gain later, so involve your tax adviser from the letter of intent.
What is the second bite of the apple?
It’s the payout on your rollover equity when the private equity sponsor sells the platform, often several years after your original sale. If the platform has grown, the second bite can be significant. If it struggled or carries heavy debt, the payout may be small or nothing.
What happens to my rollover equity if I leave early?
It depends on your agreements. Rollover equity is often subject to forfeiture, repurchase at a discount or a reduced price if you stop providing services, especially if you leave without good reason or are terminated for cause. Read the vesting and repurchase terms before signing.
Can I negotiate my non-compete when selling my practice?
Yes. Length, radius, the services covered and what happens if you’re terminated without cause are all negotiable. Sale-related non-competes are generally more enforceable than employment ones, but state laws vary and many now limit physician non-competes. Have your own attorney review both agreements.
Plastic surgery rollover equity: the bottom line
Plastic surgery rollover equity can turn a good sale into a great one, or leave you holding a stake worth far less than expected. Understand what you’re receiving, how much debt sits ahead of it, when the sponsor plans to sell, and how your employment and non-compete terms tie in. Then compare offers on the whole deal.
| Weighing an offer, or facing a platform sale? Get the Plastic Surgery Exit Report newsletter for quarterly deal updates, or book a confidential conversation with the plastic surgery team at Olympic M&A. Disclosure: Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm. |
